ClinicalTrials.gg
RecruitingNCT02771496Updated May 27, 2026

Osteochondritis Dissecans of Knee Prospective Cohort

An observational study in Osteochondritis Dissecans, sponsored by University of Pennsylvania. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-05-27.

Sponsored by University of Pennsylvania · Observational

From the registry’s dates

  • Started May 2014; still recruiting 12 years 6 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
3,000
Sex
All
01

Study summary

The Cohort is a multi-site prospective data collection study that will enroll any patient with diagnosis of knee OCD (confirmed by a standard of care x-ray or MRI). Patients will be followed for up to the next 50 years of their lives to study courses of care, disease progression, treatment/surgical options/results, and specific sports-related outcomes in athletic patients. Subjects will complete quality of life surveys as part of the Cohort. Course of care will not be affected.

Read the detailed description

Patients will be recruited and consented at the visit in which their eligibility is determined. Once a patient is eligible and provides informed consent, he or she will be in the study for up to 50 years, or until his or her OCD lesion is healed successfully.

At the initial visit, a subject will complete a basic medical history form, and three questionnaires: the IKDC Subjective questionnaire (ages over 18) or the PEDI-IKDC Subjective questionnaire (ages under 18); the KOOS questionnaire; and the Marx Activity Scale (adult) or Pedi-FABS Scale (pediatric). Patients will then continue with their normal course of care as determined by their surgeon and care team.

Mandatory surveys (same as above) will be collected from patients at 2 years, 5 years, 10 years, and 25 years. Patients who cannot return to clinic will have the option to complete the assessments and return in pre-stamped and addressed return envelopes provided by the clinical site the subject is a patient at. Any other follow-up visits between these time intervals will also be options for patients to complete these assessments, however patients will not complete them any closer than intervals 12 weeks apart in order to prevent redundancy.

Additionally, at the initial visit, the surgeon will complete a routine patient history and physical exam, which will be collected. Any surgical procedures or physical therapy a patient undergoes for treatment of his or her OCD lesion will also be documented and collected. At follow-up visits, surgeons will complete their own physical exam follow-up assessment forms, which will be collected.

02

Conditions studied

  • Osteochondritis Dissecans
03

In context

Osteochondritis Dissecans

30 studies on the registry are indexed under Osteochondritis Dissecans; 7 are open to participants now.

This study's planned enrollment of 3,000 is above the median of 130 across 12 observational studies indexed under Osteochondritis Dissecans.

Browse Osteochondritis Dissecans studies →

Lead sponsor

University of Pennsylvania is the lead sponsor of 1,668 studies on the registry; 235 are open to participants now.

Of its 158 completed or terminated interventional studies of FDA-regulated products, 109 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients of all ages with osteochondritis dissecans (OCD) or focal articular cartilage defects confirmed via MRI or x-ray.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of osteochondritis dissecans or focal articular cartilage defects as confirmed by x-ray or MRI

Exclusion criteria

Exclusion Criteria:

  • Non-confirmed diagnosis (i.e. patient does not yet have imaging confirmation)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
3,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with OCD

    Patients with diagnosis of OCD as confirmed by x-ray or MRI. Surveys collected from patients at 2 years, 5 years, 10 years, and 25 years.

    Other: Other: observational only- no intervention

Interventions

  • OtherOther: observational only- no intervention

    Other: observational only- no intervention

06

What researchers measure

Primary outcomes

  1. IKDC questionnaire

    The primary outcome endpoint for this study is the patient's score on the IKDC Subjective questionnaire, or PEDI-IKDC Subjective questionnaire for patients under 18 years of age.

    Time frame: baseline up to 50 years

  2. PEDI-IKDC questionnaire

    The primary outcome endpoint for this study is the patient's score on the IKDC Subjective questionnaire, or PEDI-IKDC Subjective questionnaire for patients under 18 years of age.

    Time frame: baseline up to 50 years

Secondary outcomes

  1. KOOS Knee score

    The Knee injury and Osteoarthritis Outcome Score (KOOS) evaluates short-term and long-term symptoms and function in subjects with knee injury and osteoarthritis.

    Time frame: baseline up to 50 years

  2. Marx Activity Score questionnaire

    Measure of physical activity at healthiest and most active state from time of taking to year prior.

    Time frame: baseline up to 50 years

  3. Pedi-FABS Score

    An eight-item scale that measures level of physical activity and fitness.

    Time frame: baseline up to 50 years

  4. Radiographic Healing

    Visualization of bone healing through x-ray images.

    Time frame: baseline up to 50 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • ROCK Group; Nissen CW, Albright JC, Anderson CN, Busch MT, Carey JL, Carlson C, Carsen S, Chambers HG, Crepeau A, Edmonds EW, Ellermann JM, Ellis HB Jr, Erickson JB, Fabricant PD, Godin J, Ganley TJ, Green DW, Grimm NL, Heyworth BE, Hui Hoi Po J, Kocher MS, Koehler R, Krych AJ, Latz KH, Loveland DM, Lyon RM, Meenen NM, Milewski MD, Myer GD, Nelson BJ, Nepple JJ, Nguyen JC, Pace JL, Paterno MV, Pennock AT, Perkins CA, Polousky JD, Riley P, Saluan P, Shea KG, Tompkins MA, Wall EJ, Weiss JM, Willimon SC, Wilson PL, Wright RW, Kostyun RO. The Efficacy of Bracing in Nonoperative Care of Medial Femoral Condyle Osteochondritis Dissecans: A Study From the Research in Osteochondritis Dissecans of the Knee (ROCK) Study Group. Am J Sports Med. 2026 May;54(6):1415-1422. doi: 10.1177/03635465261429407. Epub 2026 Apr 14. PubMed 41981903 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2014 (actual). Primary completion is estimated for May 2074, 720 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 10, 2016
First posted
May 13, 2016
StartActual
May 1, 2014
Primary completionEst.
May 1, 2074
CompletionEst.
Dec 1, 2074
Last update
May 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02771496
Collaborators
Altona Children's Hospital, Boston Children's Hospital, Children's Hospital Medical Center, Cincinnati, Children's Health Andrews Institute for Orthopaedics & Sports Medicine, Children's Healthcare of Atlanta, Children's Hospital Colorado, Children's Hospital of Philadelphia, Children's Hospital and Health System Foundation, Wisconsin, Children's Mercy Hospital Kansas City, Connecticut Children's Medical Center, Hospital for Special Surgery, New York, Kaiser Permanente, Mayo Clinic, National University Hospital, Singapore, Rady Children's Hospital, San Diego, Stanford University, Tennessee Orthopedic Alliance, Texas Scottish Rite Hospital for Children, The Rocky Mountain Hospital for Children, The Hospital for Sick Children, Göteborg University, University of Minnesota/TRIA Orthopaedic Center, Washington University School of Medicine
Responsible party
Sponsor
First posted
May 13, 2016
Start date
May 1, 2014
Primary completion
May 1, 2074 (estimated)
Completion
Dec 1, 2074 (estimated)
Last update
May 27, 2026

Study contacts

Mounika Ponakala, MS
Contact
mounika.ponakala@pennmedicine.upenn.edu
6093343767
James L Carey, MD
principal investigator · University of Pennsylvania

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion